Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Public ClinicalTrials.gov record NCT00274547. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Assessing the Proportion of Patients Experiencing an Exacerbation and Proportion of Patients Hospitalized for an Exacerbation Over 6 Months During Treatment With Tiotropium 18 Mcg Capsule Once Daily in Patients With COPD in a Veterans Affairs Setting
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this trial is to determine whether treatment with tiotropium (18 mcg) capsule once daily via the HandiHaler reduces the proportion of patients with COPD experiencing an exacerbation and the proportion of patients hospitalized for an exacerbation during a six month observation period.
Study identification
- NCT ID
- NCT00274547
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,829 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2001 (Type not available)
- Primary completion
- Feb 2003 (Actual)
- Completion
- Not listed
- Last update posted
- Nov 1, 2013
Started 2001
United States locations
- U.S. sites
- 26
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Boehringer Ingelheim Investigational Site | Birmingham | Alabama | — | — |
| Carl T. Hayden VA Medical Center | Phoenix | Arizona | — | — |
| Southern Arizona VA Health Care System | Tuscon | Arizona | — | — |
| VA Long Beach Healthcare System | Long Beach | California | — | — |
| Boehringer Ingelheim Investigational Site | Palo Alto | California | — | — |
| Respiratory Diseases (111A) | Bay Pines | Florida | — | — |
| J. Hillis Miller Health Center | Gainesville | Florida | — | — |
| Veteran Affairs Medical Center | Hines | Illinois | — | — |
| Veterans Affairs Medical Center | North Chicago | Illinois | — | — |
| Boehringer Ingelheim Investigational Site | Indianapolis | Indiana | — | — |
| Boehringer Ingelheim Investigational Site | Lexington | Kentucky | — | — |
| 4720 I-10 Service Road | Metairie | Louisiana | — | — |
| Boehringer Ingelheim Investigational Site | Boston | Massachusetts | — | — |
| Veteran Affairs Medical Center | Minneapolis | Minnesota | — | — |
| Boehringer Ingelheim Investigational Site | Kansas City | Missouri | — | — |
| Boehringer Ingelheim Investigational Site | Omaha | Nebraska | — | — |
| Boehringer Ingelheim Investigational Site | Reno | Nevada | — | — |
| Boehringer Ingelheim Investigational Site | Buffalo | New York | — | — |
| Bronx VA Medical Center | New York | New York | — | — |
| Boehringer Ingelheim Investigational Site | Durham | North Carolina | — | — |
| Dallas VAMC | Dallas | Texas | — | — |
| Veterans Affairs Medical Center | Houston | Texas | — | — |
| Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| Boehringer Ingelheim Investigational Site | Salt Lake City | Utah | — | — |
| Hampton VA Medical Center | Hampton | Virginia | — | — |
| Hunter Holmes McGuire Medical Center | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00274547, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2013 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00274547 live on ClinicalTrials.gov.